Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
Neurology|September 20, 2000
Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patientsC G Goetz, L M Blasucci, S Leurgans, et al.
Neurology|June 1, 1985
Pergolide mesylate: lack of cardiac toxicity in patients with cardiac diseaseC M Tanner, R Chhablani, C G Goetz, et al.
Archives of Neurology|October 13, 2000
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's diseaseK Kujawa, S Leurgans, R Raman, et al.
Annals of Neurology|April 1, 1991
Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's diseaseJ H Kordower, E Cochran, R D Penn, et al.
The Journal of Clinical Psychiatry|April 1, 1985
The pathophysiology of tardive dyskinesiaH L Klawans, P Carvey, C M Tanner, et al.
Neurology|September 25, 1998
Early dopaminergic drug-induced hallucinations in parkinsonian patientsC G Goetz, C Vogel, C M Tanner, et al.
Archives of Neurology|July 25, 1998
Clinical presentation and pharmacological therapy in corticobasal degenerationK Kompoliti, C G Goetz, B F Boeve, et al.
Life Sciences|April 9, 1984
Neuroleptic-induced dopamine hyposensitivityC G Goetz, P M Carvey, C M Tanner, et al.
Brain and Cognition|November 1, 1992
Ideational fluency in Parkinson's diseaseR S Wilson, D W Gilley, C M Tanner, et al.
Neurology|November 1, 1989
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopaC G Goetz, C M Tanner, D W Gilley, et al.
Pageof 19